Immunotherapy for Prostate Cancer: Where Do We Go From Here … – UroToday
OncLive |
Immunotherapy for Prostate Cancer: Where Do We Go From Here …
UroToday Immunotherapies have emerged as a revolutionary modality for cancer treatment, and a variety of immune-based approaches are currently being investigated in the field of prostate cancer. Despite the 2010 approval of sipuleucel-T, subsequent progress in … Dr. Gomella on Immunotherapy Developments in Prostate Cancer |
